| 120.78 7.505 (6.63%) | 11-25 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 141.4 |
1-year : | 165.16 |
| Resists | First : | 121.06 |
Second : | 141.4 |
| Pivot price | 105.34 |
|||
| Supports | First : | 100.97 |
Second : | 88.55 |
| MAs | MA(5) : | 111.61 |
MA(20) : | 102.01 |
| MA(100) : | 85.47 |
MA(250) : | 90.74 |
|
| MACD | MACD : | 6 |
Signal : | 4.7 |
| %K %D | K(14,3) : | 94.5 |
D(3) : | 86.6 |
| RSI | RSI(14): 82.3 |
|||
| 52-week | High : | 121.06 | Low : | 66 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CURE ] has closed above the upper band by 3.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 114% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 121.25 - 121.74 | 121.74 - 122.24 |
| Low: | 113.32 - 113.81 | 113.81 - 114.32 |
| Close: | 119.94 - 120.83 | 120.83 - 121.74 |
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Thu, 20 Nov 2025
Direxion's 5 Single-Stock ETFs, Including Coinbase and Robinhood - ETF Trends
Wed, 19 Nov 2025
Top Performing Leveraged/Inverse ETFs: 11/16/2025 - ETF Database
Sun, 16 Nov 2025
(CURE) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Wed, 05 Nov 2025
(CURE) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Tue, 04 Nov 2025
These Stocks Could Be Catalysts for CURE - ETF Trends
Fri, 29 Aug 2025
CURE: Adding Defensive Exposure Amid Frothy Market Valuations (NYSEARCA:CURE) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |